Skip to main content

Table 4 Relationships between BRAF V600E alone or RET fusion alone or BRAF + TERT or BRAF + RAS mutations and clinicopathological features in PTC patients

From: Genomic characterization of high-recurrence risk papillary thyroid carcinoma in a southern Chinese population

Characteristics

BRAF V600E

RET Fusion

BRAF + TERT

BRAF + RAS

Positive (N = 119)

Negative (N = 49)

P-value

Positive (N = 13)

Negative (N = 155)

P-value

Positive (N = 10)

Negative (N = 158)

P-value

Positive (N = 7)

Negative (N = 161)

P-value

Gender

 Female

92 (77.3)

39 (79.6)

0.746

9 (71.4)

122 (78.6)

0.428

7 (70.0)

124 (78.5)

0.530

6 (85.7)

125 (77.6)

0.614

 Male

27 (22.7)

10 (20.4)

 

4 (28.6)

33 (21.4)

 

3 (30.0)

34 (21.5)

 

1 (14.3)

36 (22.4)

 

Age

 < 45

73 (61.3)

34 (69.4)

0.324

11 (85.7)

96 (61.7)

0.102

2 (20.0)

105 (66.5)

0.003*

5 (71.4)

102 (63.4)

0.679

 ≥ 45

46 (38.7)

15 (30.6)

 

2 (14.3)

59 (38.3)

 

8 (80.0)

53 (33.5)

 

2 (28.6)

58 (36.6)

 

Subtypes

 conventional PTC

116 (97.5)

40 (81.6)

< 0.001*

11 (85.7)

145 (93.5)

0.230

10 (100)

146 (92.4)

0.366

7 (100)

149 (92.5)

0.454

 follicular variant PTC

3 (2.5)

9 (18.4)

 

2 (14.3)

10 (6.5)

 

0 (0)

12 (7.6)

 

0 (0)

12 (7.5)

 

Lymph node metastasis

 Yes

107 (89.9)

42 (85.7)

0.434

12 (92.9)

137 (88.3)

0.668

9 (90.0)

140 (88.6)

0.893

6 (85.7)

143 (88.8)

0.800

 No

12 (10.1)

7 (24.3)

 

1 (7.1)

18 (11.7)

 

1 (10.0)

18 (11.4)

 

1 (14.3)

18 (11.2)

 

AJCC disease stage

 I + II

75 (63.0)

34 (69.4)

0.432

11 (85.7)

98 (63.0)

0.121

2 (20.0)

107 (67.7)

0.002*

5 (71.4)

104 (64.6)

0.711

 III + IV

44 (37.0)

15 (30.6)

 

2 (14.3)

57 (37.0)

 

8 (80.0)

51 (32.3)

 

2 (28.6)

57 (35.4)

 

Lesion number

 Single lesion

54 (55.5)

24 (75.5)

0.671

10 (76.9)

93 (60.0)

0.655

2 (20.0)

76 (63.9)

0.084

0 (28.6)

78 (62.7)

0.015*

 Multiple lesions

65 (44.5)

25 (24.5)

 

3 (23.1)

62 (40.0)

 

8 (80.0)

82 (36.1)

 

7 (71.4)

83 (37.3)

 
  1. Values are presented as number (%). *p < 0.05. BRAF+RAS means BRAF+NRAS and BRAF+HRAS and BRAF+KRAS dual mutations together